Alprazolam updated on 02-10-2025

Preterm (< 37 weeks)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17849
R75327
Meng a (Controls unexposed, sibling), 2023 Preterm birth (<37 weeks’ gestation) early pregnancy population based cohort retrospective sibling excluded Adjustment: Yes BZD Coexposure: Yes (with psychiatric (ATD and/or psychotropics) medications) 1.08 [0.94;1.24]
excluded (control group)
-/-   -/- - -
ref
S15628
R64508
Meng a (Controls unexposed, sick), 2023 Preterm birth (<37 weeks’ gestation) early pregnancy population based cohort retrospective unexposed, sick Adjustment: Yes BZD Coexposure: Yes (with psychiatric (ATD and/or psychotropics) medications) 1.19 [1.13;1.26] 1,614/14,138   274,556/2,808,074 276,170 14,138
ref
S15643
R64561
Lee, 2022 Preterm birth (< 37 weeks) 1st trimester prospective cohort unexposed (general population or NOS) Adjustment: Yes BZD Coexposure: Not specified 2.27 [0.92;5.60] 7/82   22/579 29 82
ref
Total 2 studies 1.40 [0.81;2.41] 276,199 14,220
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Meng a (Controls unexposed, sick), 2023Meng a, 2023 1 1.19[1.13; 1.26]276,17014,13875%ROB confusion: lowROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Lee, 2022Lee, 2022 2.27[0.92; 5.60]298225%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: criticalROB mesure: unclearROB reporting: moderate Total (2 studies) I2 = 49% 1.40[0.81; 2.41]276,19914,2200.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.40[0.81; 2.41]276,19914,22049%NAMeng a (Controls unexposed, sick), 2023 Lee, 2022 2 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 2.27[0.92; 5.60]2982 -NALee, 2022 1 unexposed, sickunexposed, sick 1.19[1.13; 1.26]276,17014,138 -NAMeng a (Controls unexposed, sick), 2023 1 Tags Adjustment   - Yes  - Yes 1.40[0.81; 2.41]276,19914,22049%NAMeng a (Controls unexposed, sick), 2023 Lee, 2022 2 BZD Coexposure   - Not specified  - Not specified 2.27[0.92; 5.60]2982 -NALee, 2022 1   - Yes (with psychiatric (ATD and/or p ...  - Yes (with psychiatric (ATD and/or psychotropics) medications) 1.19[1.13; 1.26]276,17014,138 -NAMeng a (Controls unexposed, sick), 2023 1 All studiesAll studies 1.40[0.81; 2.41]276,19914,22049%NAMeng a (Controls unexposed, sick), 2023 Lee, 2022 20.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 17849

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 2.27[0.92; 5.60]2982 -NALee, 2022 1 unexposed, sick controlsunexposed, sick controls 1.19[1.13; 1.26]276,17014,138 -NAMeng a (Controls unexposed, sick), 2023 1 siblingssiblings 1.08[0.94; 1.24]-- -NAMeng a (Controls unexposed, sibling), 2023 10.510.01.0